In this issue:
Benefits to BSO in BRCA1/2 carriers with a history of breast cancer
Impact of lymphadenectomy rates in early ovarian cancer
Robotic secondary cytoreduction is feasible for isolated recurrent ovarian cancer
Is HIPEC during cytoreductive surgery beneficial for advanced-stage disease?
Management paradigms and outcomes in patients with O-NEC
Olaparib maintenance for non-germline BRCA mutated relapsed disease
Surgical complexity does not impact outcomes in newly diagnosed patients
ADNEX model may aid in early detection of malignant adnexal masses
Indocyanine green as a tracer for SLN biopsy
Neoadjuvant chemotherapy enables delayed surgery in some patients with relapsed disease
Please login below to download this issue (PDF)